Abstract:Background & Aims : Nowadays, the global prevalence of non-alcoholic fatty liver disease (NAFLD) has reached about 25%, which is the most common chronic liver disease worldwide, and the mortality risk of NAFLD patients is higher. Our research created five machine learning (ML) models for predicting overall mortality in ultrasound-proven NAFLD patients and compared their performance with conventional non-invasive scoring systems, aiming to find a generalizable and valuable model for early mortality prediction in NAFLD patients. Methods: National Health and Nutrition Examination Survey (NHANES)-III from 1988 to 1994 and NHANES-III related mortality data from 2019 were used. 70% of subjects were separated into the training set (N = 2262) for development, while 30% were in the testing set (N= 971) for validation. The outcome was all-cause death at the end of follow-up. Twenty-nine related variables were trained as predictor features for five ML–based models: Logistic regression (LR), K-nearest neighbors (KNN), Gradient-boosted decision tree (XGBoost), Random forest (RF) and Decision tree. Five typical evaluation indexes including area under the curve (AUC), F1 score, accuracy, sensitivity and specificity were used to measure the prediction performance. Results: 3233 patients with NAFLD in total were eligible for the inclusion criteria, with 1231 death during the average 25.3 years follow up time. AUC of the LR model in predicting the mortality of NAFLD was 0.888 (95% confidence interval [CI] 0.867-0.909), the accuracy was 0.808, the sensitivity was 0.819, the specificity was 0.802, and the F1 score was 0.765, which showed the best performance compared with other models (AUC were: RF, 0.876 [95%CI 0.852-0.897]; XGBoost, 0.875 [95%CI 0.853-0.898]; Decision tree, 0.793 [95%CI 0.766-0.819] and KNN, 0.787 [95%CI 0.759-0.816]) and conventional clinical scores (AUC were: Fibrosis-4 Score (FIB-4), 0.793 [95%CI 0.777-0.809]; NAFLD fibrosis score (NFS), 0.770 [95%CI 0.753-0.787] and aspartate aminotransferase-to-platelet ratio index (APRI), 0.522 [95%CI 0.502-0.543]). Conclusions: ML–based models, especially LR model, had better discrimination performance in predicting all-cause mortality in patients with NAFLD compared to the conventional non-invasive scores, and an interpretable model like Decision tree, which only used three predictors: age, systolic pressure and glycated hemoglobin, is simple to use in clinical practice.

Factors and a model to predict three-month mortality in patients with acute fatty liver of pregnancy from two medical centers

Risk Factors for Maternal and Fetal Mortality in Acute Fatty Liver of Pregnancy and New Predictive Models

Analysis of clinical characteristics and genetic testing in patients with acute fatty liver of pregnancy: a retrospective study

A Multifactor Model for Predicting Mortality in Critically Ill Patients: A Multicenter Prospective Cohort Study

A Modified Meld Model For Chinese Pre-Aclf And Aclf Patients And It Reveals Poor Prognosis In Pre-Aclf Patients

The analysis and summaries of 13 cases with acute fatty liver of pregnancy

Prognostic Models for Acute Liver Failure.

Development and Validation of Nomograms to Predict Clinical Outcomes of Preeclampsia

Machine learning-based mortality prediction models for non-alcoholic fatty liver disease in the general United States population

Early diagnostic test for acute fatty liver of pregnancy: a retrospective case control study

Development and Validation of a New Prognostic Model for Predicting Survival Outcomes in Patients with Acute-on-chronic Liver Failure

ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population

A predictive model of pregnancy loss using pre-pregnancy endocrine and immunological parameters in women with abnormal glucose/lipid metabolism and previous pregnancy loss

Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms

Predicting the 28-day prognosis of acute-on-chronic liver failure patients based on machine learning

A novel clinical prediction model of severity based on red cell distribution width, neutrophil-lymphocyte ratio and intra-abdominal pressure in acute pancreatitis in pregnancy

A nutrition-based radiomics–clinical model to predict the prognosis of patients with acute-on-chronic liver failure

Multivariate analysis of prognostic factors for fulminant hepatitis in pregnancy

Development and validation of machine learning models for nonalcoholic fatty liver disease

Early Diagnosis and Treatment of Acute Fatty Liver of Pregnancy

Predictive efficacy of machine-learning algorithms on intrahepatic cholestasis of pregnancy based on clinical and laboratory indicators